DRKS00023404已完成不适用
Secondary Immunodeficiencies and Infections in patients with hematologic malignancies treated with anti-CD20-antibodies - SIDI-20
Institut für Versorgungsforschung in der Onkologie GbR0 个研究点目标入组 100 人开始时间: 2021年2月16日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Diagnosis of a B-cell lymphoma in need of therapy. Planned 1st line therapy with an anti-CD20 antibody (rituximab, obinutuzumab, ofatumumab). Age = 18 years, signed informed consent, sufficient knowledge of German language
排除标准
- •Antibody therapy started before inclusion
研究者
相似试验
招募中
不适用
Primary Immunodeficiencies: immunological and genetic background in relation to clinical complicationsimmune disordersprimary immune deficiencies1002146010027946NL-OMON55725Erasmus MC, Universitair Medisch Centrum Rotterdam1,500
已完成
不适用
Intensive Care Unit and Secondary and Primary Immune DeficiencyPrimary Immune Deficiency DisorderNCT02888535University Hospital, Caen16
已完成
不适用
Immunological factors of pain and infection in patients with burnsinfectie en pijn bij brandwondenPain and infection in burns1000401810014982NL-OMON39434Vereniging Samenwerkende Brandwondencentra Nederland55
尚未招募
不适用
Relationship between Immunological Dysfunction and Traditional Chinese Medicine Syndrome Differentiation in Septic Patients: a prospective cohort studySepsisITMCTR1900002556Department of Intensive Care Unit, the First Affiliated Hospital of Guangzhou University of Chinese Medicine
招募中
不适用
Primary Immunodeficiencies impacting regulatory T cell biologyE31.0D84D82D89Autoimmune polyglandular failureOther immunodeficienciesImmunodeficiency associated with other major defectsOther disorders involving the immune mechanism, not elsewhere classifiedDRKS00017386niversitätsklinikum Freiburg50